A ‘natural’ pacemaker that mimics the heart’s variable rhythm is being trialled in humans for the first time with no adverse effects reported and the promise of improved outcomes.
The first-in-human trials started in the Waikato just before Christmas and now are being conducted in Adelaide and Melbourne, Australia, and Bristol and Cardiff in the UK.
Read the full article here.
A practical look at why Design for Manufacture is critical in medtech, and how early consideration of manufacturing, regulatory and commercial requirements can help innovators reduce risk and successfully scale medical devices
NZ Medtech Scene
Yaara Yarmut, Chief Regulatory Officer at Alimetry, explains how early planning can reduce redesign, avoid wasted investment and help ensure MedTech products meet user, market and regulatory needs
.jpg)
NZ Medtech Scene
Design and manufacturing in Medtech doesn’t always fit neatly within a single industry box. Some of the strongest solutions come from bringing in expertise from other sectors like design and manufacturing.